Article published the August 22, 2019
Background and objectivesWithout clear and accurate definition of gut health status, the design of feeding trials to study alternatives to in-feed therapeuticals (antibiotics and zinc oxide) is a challenge. Growth performance and clinical signs of scours remain the key measurements for feed evaluation, but they may not allow to discriminate solutions in a repeatable manner. Niewold (2015) proposed ...
This member had joined Engormix
August 22, 2019